Immutep Limited
PRRUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1 | $3 | $2 | $2 |
| % Growth | -69.9% | 81.8% | -18% | – |
| Cost of Goods Sold | $18 | $25 | $21 | $1 |
| Gross Profit | -$17 | -$22 | -$19 | $1 |
| % Margin | -1,802.8% | -704.7% | -1,119.4% | 52.8% |
| R&D Expenses | $18 | $25 | $21 | $20 |
| G&A Expenses | $2 | $4 | $4 | $5 |
| SG&A Expenses | $2 | $4 | $4 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $20 | $30 | $25 | $25 |
| Operating Income | -$37 | -$52 | -$45 | -$44 |
| % Margin | -3,938.3% | -1,644% | -2,572.9% | -2,063.9% |
| Other Income/Exp. Net | $18 | $15 | $23 | $22 |
| Pre-Tax Income | -$20 | -$11 | -$21 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20 | -$22 | -$21 | -$21 |
| % Margin | -2,059.8% | -710.9% | -1,241.3% | -1,005.7% |
| EPS | -0.013 | -0.015 | -0.018 | -0.018 |
| % Growth | 13% | 13% | 0% | – |
| EPS Diluted | -0.013 | -0.015 | -0.018 | -0.018 |
| Weighted Avg Shares Out | 1,459 | 1,453 | 1,214 | 1,197 |
| Weighted Avg Shares Out Dil | 1,459 | 1,453 | 1,216 | 1,197 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $1 | $1 |
| EBITDA | -$18 | -$26 | -$22 | -$22 |
| % Margin | -1,924.1% | -838.5% | -1,290.8% | -1,051.7% |